PedAM
Pediatric Disease Annotations & Medicines
| Disease | myositis |
| Symptom | C0206062|interstitial lung disease |
| Sentences | 4 |
| PubMedID- 23531196 | Given the recurrence of myositis with association of interstitial lung disease poorly controlled by immunosuppressive therapy (tacrolimus, cyclosporine) and considering the documented efficacy of immunosuppressive therapy with rituximab in the treatment of resistant forms of dermatomyositis with anti-jo1 antibodies, the administration of this drug during hospitalization (after permission from the ethic committee) was proposed to the patient and she did not present any adverse effects. |
| PubMedID- 25837172 | Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. |
| PubMedID- 20387195 | The anti-jo-1 syndrome - a specific form of myositis with interstitial lung disease. |
| PubMedID- 25203119 | Purpose of review: to highlight recent advances in understanding the clinical spectrum, pathogenesis, and treatment of interstitial lung disease associated with inflammatory myositis and the antisynthetase syndrome. |
Page: 1